Here are the DEF 14A proxy statements from Cardinal Health, Inc. (CAH) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow CAH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CAH filings page.
Cardinal Health, Inc. (CAH) is soliciting shareholder votes for its 2026 virtual annual meeting, where investors will elect 11 directors, approve on an advisory basis named executive officer pay, and ratify Ernst & Young LLP as independent auditor for the year ending June 30, 2027.
The proxy details strong fiscal 2026 results, including broad-based profit growth across all five operating segments, double-digit gains in GAAP and non-GAAP operating earnings, and significant increases in operating cash flow and earnings per share. One-year total shareholder return was robust, and three-year return was substantially higher, reflecting execution on strategic priorities in Pharmaceutical and Specialty Solutions, Global Medical Products and Distribution, and growth businesses such as Nuclear and Precision Health Solutions, at-Home Solutions, and OptiFreight Logistics.
The Board highlights an independent Chair structure, committee-only independent membership, enhanced enterprise risk management oversight through the Risk Oversight Committee, and an extensive shareholder engagement program. Recent board refreshment, leadership transitions, and a structured evaluation and education process are emphasized as key elements supporting long-term strategy, risk oversight, and sustainable value creation.